| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/DKV098 |
| P8608 | Fatcat ID | release_obvu7edj75c5zgcnlzq73esazi |
| P698 | PubMed publication ID | 25925594 |
| P2093 | author name string | Juan V Esplugues | |
| Nadezda Apostolova | |||
| Ana Blas-Garcia | |||
| Haryes A Funes | |||
| P2860 | cites work | Hypometabolism as a therapeutic target in Alzheimer's disease | Q21262020 |
| Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND). | Q31159582 | ||
| Bioenergetic characterization of mouse podocytes | Q34085737 | ||
| Assessing mitochondrial dysfunction in cells. | Q34793639 | ||
| Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease | Q34801664 | ||
| The acute extracellular flux (XF) assay to assess compound effects on mitochondrial function | Q35405000 | ||
| Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration | Q36667153 | ||
| Neuropsychiatric side effects of efavirenz therapy | Q36762436 | ||
| Advances in measuring cellular bioenergetics using extracellular flux | Q37110791 | ||
| Implications of efavirenz for neuropsychiatry: a review. | Q37801927 | ||
| Involvement of nitric oxide in the mitochondrial action of efavirenz: a differential effect on neurons and glial cells. | Q38925613 | ||
| Neuronal bioenergetics and acute mitochondrial dysfunction: a clue to understanding the central nervous system side effects of efavirenz | Q38996720 | ||
| Cell surface oxygen consumption: a major contributor to cellular oxygen consumption in glycolytic cancer cell lines | Q40176788 | ||
| The antiretroviral protease inhibitors indinavir and nelfinavir stimulate Mrp1-mediated GSH export from cultured brain astrocytes | Q44176745 | ||
| Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. | Q48462986 | ||
| Mitochondrial bioenergetics and drug-induced toxicity in a panel of mouse embryonic fibroblasts with mitochondrial DNA single nucleotide polymorphisms. | Q52741772 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | efavirenz | Q422645 |
| P304 | page(s) | 2249-2254 | |
| P577 | publication date | 2015-04-29 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Efavirenz alters mitochondrial respiratory function in cultured neuron and glial cell lines | |
| P478 | volume | 70 |
| Q38628801 | An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge? |
| Q37691000 | Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children |
| Q40051820 | Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals |
| Q92150931 | Circular RNA NF1-419 enhances autophagy to ameliorate senile dementia by binding Dynamin-1 and Adaptor protein 2 B1 in AD-like mice |
| Q90253728 | Combination of Tenofovir and Emtricitabine with Efavirenz Does Not Moderate Inhibitory Effect of Efavirenz on Mitochondrial Function and Cholesterol Biosynthesis in Human T Lymphoblastoid Cell Line |
| Q39364925 | Consequences of a Chronic Exposure of Cultured Brain Astrocytes to the Anti-Retroviral Drug Efavirenz and its Primary Metabolite 8-Hydroxy Efavirenz. |
| Q89398971 | Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy |
| Q92570343 | Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART |
| Q38645161 | In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals. |
| Q59355519 | Nanoformulated Antiretroviral Therapy Attenuates Brain Metabolic Oxidative Stress |
| Q36330202 | Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment |
| Q61797159 | Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent model |
| Q92135854 | Neuropsychiatric and Neurocognitive Manifestations in HIV-Infected Children Treated With Efavirenz in South Africa-A Retrospective Case Series |
| Q38882614 | Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics |
| Q90140528 | The far-reaching HAND of cART: cART effects on astrocytes |
Search more.